{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T02:10:01Z","timestamp":1734228601490,"version":"3.30.2"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.transproceed.2004.01.009","type":"journal-article","created":{"date-parts":[[2004,1,29]],"date-time":"2004-01-29T10:14:44Z","timestamp":1075371284000},"page":"S504-S508","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S","title":["The promise of C2, simulect, and certican in heart transplantation"],"prefix":"10.1016","volume":"36","author":[{"given":"D.H","family":"Delgado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2004.01.009_BIB1","first-page":"620","article-title":"2001 Canadian cardiovascular society consensus conference on cardiac transplantation","volume":"19","author":"Ross","year":"2003","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB2","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1001\/jama.280.19.1692","article-title":"Current status of cardiac transplantation","volume":"280","author":"Hunt","year":"1998","journal-title":"JAMA"},{"year":"1999","series-title":"Immunosuppression in Transplantation","author":"Ginns","key":"10.1016\/j.transproceed.2004.01.009_BIB3"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB4","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0041-1345(00)00862-9","article-title":"Neoral use in the cardiac transplant recipient","volume":"32","author":"Valentine","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/00007890-198811000-00017","article-title":"The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant patients","volume":"46","author":"Kasiske","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB6","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/S0041-1345(00)01338-5","article-title":"Neoral monitoring","volume":"32","author":"Cole","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007890-199907150-00011","article-title":"Neoral monitoring by simplified sparse sampling area under the concentration-time curve","volume":"68","author":"Mahalati","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB8","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1097\/00007890-199612270-00009","article-title":"A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian neoral renal transplantation study group","volume":"62","author":"Keon","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00007890-199904270-00008","article-title":"Peak cyclosporine levels (Cmax) correlated with freedom from liver graft rejection","volume":"67","author":"Grant","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007890-199907150-00011","article-title":"Neoral monitoring by simplified sparse sampling area under the concentration-time curve","volume":"68","author":"Mahalati","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/00007890-200203270-00003","article-title":"Improved clinical outcomes for liver transplant recipients using cyclosporine based on 2-hr post-dose levels (C2)","volume":"73","author":"Levy","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB12","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0041-1345(99)00086-X","article-title":"Relationship of pharmacokinetics to clinical outcomes","volume":"31","author":"Levy","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB13","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/00007890-199812270-00009","article-title":"Comparison of neoral dose monitoring with cyclosporine trough levels versus 2- hr postdose levels in stable liver transplant patients","volume":"66","author":"Cantarovich","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB14","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/00007890-199812270-00009","article-title":"Comparison of neoral dose monitoring with cyclosporine trough levels versus 2- hr postdose levels in stable liver transplant patients","volume":"66","author":"Cantarovich","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB15","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00007890-199912270-00003","article-title":"Clinical benefit of neural dose monitorin with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients","volume":"68","author":"Cantarovich","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1399-0012.1998.tb01098.x","article-title":"Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy","volume":"12","author":"Cantarovich","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1053-2498(01)00565-4","article-title":"Monitoring of cyclosporine 2-hr post-dose and trough levels in heart transplantation","volume":"21","author":"Delgado","year":"2002","journal-title":"J Heart Lung Transp"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S1053-2498(99)00100-X","article-title":"A 10-year experience with intravenous thymoglobulin in induction of immunosuppression following heart transplantation","volume":"18","author":"Carrier","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00007890-199909150-00012","article-title":"Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients","volume":"68","author":"Eisen","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-ionterleukin-2 receptor monoclonal antibody. United States Simulect Renal Study Group","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB21","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/00007890-200112270-00008","article-title":"Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection","volume":"72","author":"Sollinger","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1432-2277.2003.tb00222.x","article-title":"Safety and efficacy of an alternative basiliximab (Simulect) regimen after renal transplantation","volume":"16","author":"Matl","year":"2003","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00007890-200301150-00007","article-title":"Randomized double-blind study of immunoprophylaxis with basiliximax, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation","volume":"75","author":"Lawn","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB24","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S1053-2498(02)00903-8","article-title":"Study of the safety and tolerability of Simulect\u00ae (basiliximab) versus OKT3 in heart transplantation","volume":"22","author":"Crespo-Leiro","year":"2003","journal-title":"J Heart Lung Transplant"},{"year":"2002","series-title":"Heart transplantation","author":"Kirklin","key":"10.1016\/j.transproceed.2004.01.009_BIB25"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB26","unstructured":"Delgado DH, Miriuka S, Cusimano RJ, et al: Use of basiliximab and cyclosporine in heart transplant patients with preoperative renal dysfunction. J Heart Lung Transplant (in press)"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-199707150-00007","article-title":"SDZ RAD, new rapamycin derivative","volume":"64","author":"Schuurman","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2125.1999.00085.x","article-title":"Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients","volume":"48","author":"Neumayer","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB30","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/00007890-200105270-00008","article-title":"RAD in de novo renal transplantation","volume":"71","author":"Kahan","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0966-3274(01)00045-4","article-title":"Efficacy of SDZ RAD compared with CsA monotherapy and combined Rad\/FTY720 treatment in a murine cardiac allotransplantation model","volume":"9","author":"Nikolova","year":"2001","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2004.01.009_BIB32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134504000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134504000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T01:39:04Z","timestamp":1734226744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134504000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0041134504000107"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2004.01.009","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}